Leavell Investment Management »

Immunitybio shares owned by Leavell Investment Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Leavell Investment Management from 13F filings

Historical chart of Leavell Investment Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Leavell Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Leavell Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $86k 35k 2.46

More positions owned by Leavell Investment Management

NVIDIA Corporation (NVDA)
Vanguard Mega Cap ETF Mega Cap Index (MGC)
Apple (AAPL)
Vanguard Mid Cap ETF Mid Cap Etf (VO)
Vanguard Mega Growth ETF Mega Grwth Ind (MGK)
Microsoft Corporation (MSFT)
Vanguard S&P 500 ETF S&p 500 Etf Shs (VOO)
Vanguard FTSE Developed ETF Ftse Dev Mkt Etf (VEA)
Vanguard Large-Cap Index Fund ETF Shares Large Cap Etf (VV)
Schwab Short U.S. Treasury ETF Sht Tm Us Tres (SCHO)
Schwab Fundamental Inl Large Com ETF Schwb Fdt Int Lg (FNDF)
Vanguard Small Cap ETF Small Cp Etf (VB)
JPMorgan Chase & Co. (JPM)
iShares 1-5 Investment Grade Corp ETF 1-3 Yr Cr Bd Etf (IGSB)
Blackstone Group Com Cl A (BX)

View all positions for Leavell Investment Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio